The 22-year-old made a compelling statement during the recent ICC World T20 Cup by bowling fearlessly against the Australians in Adelaide. Farooqi finished with 2-29 after capturing the prized wickets of Cameron Green and Matt Wade. Farooqi, who has played seven ODI matches and 17 T20 intern
Mumbai (Maharashtra) [India], November 22 (ANI/NewsVoir): India's leading credit-led, AI-driven financial wellness platform, CASHe, today announced that its wholly-owned NBFC, Bhanix Finance & Investment Ltd. (BFIL) has been assigned a [ICRA] BBB (Stable) credit rating from ICRA.
It was expected he would be available for the first eight matches of the tournament. Livingstone's international commitments have increased since the Draft. He was added to England's Test squad for a series in December, with West Indian all-rounder Andre Russell signed in his place for the f
At the domestic T20 level, the right-hand, top-order batter has an impressive strike rate of 145.08, having amassed 1284 runs over 47 appearances, including a personal top-score of 108* in 2020
From the protest site, the AAP members tried to march towards the Vidhana Soudha, the state Assembly building. However, they were rounded up by the police before they could reach the Assembly.
The Congress had alleged that Hombale (now named Chilume) had been illegally revising the BBMP voters' list and Chief Minister Basavaraja Bommai and Narayan were involved in it.
Surjewala demanded a high-level probe in the matter and claimed a private agency named "Chilume" was authorised by the Bruhat Bengaluru Mahanagara Palike (BBMP) - the urban local body of Bengaluru, to carry out a door-to-door survey of voters in the city.
The 32-year-old was signed by Thunder as the club's platinum signing at the inaugural BBL draft held in August because of his stellar ability to bowl throughout an innings.
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval for market authorization of its "Five Arms" intranasal heterologous booster dose, and it has now announced that iNCOVACC (BBV154) has re